|
|
News Breaks | | | | December 13, 2012 | | 07:23 EDT |  | CYTK | Cytokinetics has potentially transformative catalysts, says JMP Securities
After attending Cytokinetics' R&D day, JMP Securities believes that the company has multiple value-inflecting and potentially transformative catalysts in 2013. The firm thinks the company may obtain a partner for its tirasemtiv treatment, and JMP Securities reiterates an Outperform rating on the shares. | |
|
News For CYTK From The Last 14 Days Check below for free stories on CYTK the last two weeks. |
|
|
| There are no results for CYTK |
|
|
|
|
|
|
